Active · per the CBE, 30 September 2026

MANAGEMENT CAROLINE VANDECASTEELE

BE0536437813

Rechtspersoon Private limited company 1 establishment

MANAGEMENT CAROLINE VANDECASTEELE is a pharmacy in Leuven. Private Limited, started on 4 July 2013, 1 establishment.

Juliaan Haestweg 7, 3012 Leuven

Behind the company: Caroline Vandecasteele.

Active for

13 year, 2 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 8 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

MANAGEMENT CAROLINE VANDECASTEELE from Leuven, company number BE0536437813, closed financial year 2025 with a result of € 180,252 after tax. For that financial year MANAGEMENT CAROLINE VANDECASTEELE recorded a gross margin of € 168,100 and equity of € 698,250. Compared with financial year 2024, the result moved from € 118,421 to € 180,252. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 4, 2026.

What it is worth Healthy

€ 698,250

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 180,252

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 28,618

▲ € 26,175 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 180,252 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

0.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 37,159

▼ 33% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 585

▼ 41% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go

€ 270,250

▼ 24% vs 2024

€ 82,027 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 3,332

▲ 214% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 41,879

▲ 91% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 193,284 € 242,213 € 223,904 € 168,100 ▼ 25%
Profit after taxes € 91,448 € 132,549 € 118,421 € 180,252 ▲ 52%
Equity € 592,281 € 664,829 € 698,250 € 698,250
Total debts € 616,595 € 557,839 € 509,641 € 530,587 ▲ 4%
Cash € 4,824 € 19,762 € 2,442 € 28,618 ▲ € 26,175
Land & buildings € 1,986 € 1,406 € 827 € 248 ▼ 70%
Retained profit € 573,681 € 646,229 € 679,650 € 679,650
Dividend € 0 € 60,000 € 85,000 € 180,252 ▲ 112%
Bank debt € 499,980 € 421,225 € 356,244 € 270,250 ▼ 24%
Balance sheet total € 1,208,876 € 1,222,668 € 1,207,891 € 1,228,837 ▲ 2%
Employees (FTE) 0.7 0.7 0.7 0.7

Key figures of MANAGEMENT CAROLINE VANDECASTEELE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MANAGEMENT CAROLINE VANDECASTEELE?

What happened at MANAGEMENT CAROLINE VANDECASTEELE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 180,252 (▲ 52% vs 2024). Source: NBB ↗
  • New establishment in Leuven. KBO
  • Start of the company according to the CBE. KBO

In short

From € 91,448 profit in 2022 to € 180,252 profit in 2025.

Paid € 123,516 in corporate taxes since 2022.

Best year ever: 2025, with € 180,252 profit.

Paid out € 325,252 in dividends to the owners in total.

Management

Caroline Vandecasteele
MANAGEMENT CAROLINE VANDECASTEELE
Pharmovan 100%

Behind MANAGEMENT CAROLINE VANDECASTEELE is Caroline Vandecasteele. It owns 100% of Pharmovan itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Caroline Vandecasteele

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Juliaan Haestweg 7

3012 Leuven

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0536.437.813
VAT number
BE 0536.437.813
Registered office
Juliaan Haestweg 7, 3012 Leuven
Names & denominations
MANAGEMENT CAROLINE VANDECASTEELE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
4 July 2013
Peppol
Active · Active since 4 Jul 2025
Activities · NACE

Detailhandel in farmaceutische producten

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Frequently asked questions

What does MANAGEMENT CAROLINE VANDECASTEELE do?
MANAGEMENT CAROLINE VANDECASTEELE is a pharmacy in Leuven. Private Limited, started on 4 July 2013, 1 establishment.
What is the address of MANAGEMENT CAROLINE VANDECASTEELE?
The registered office of MANAGEMENT CAROLINE VANDECASTEELE is located at Juliaan Haestweg 7, 3012 Leuven.
Is MANAGEMENT CAROLINE VANDECASTEELE still active?
Yes. According to the CBE (30 September 2026) MANAGEMENT CAROLINE VANDECASTEELE is active, legal situation “Normale toestand”, started on 4 July 2013.
Is MANAGEMENT CAROLINE VANDECASTEELE registered on Peppol?
Yes, MANAGEMENT CAROLINE VANDECASTEELE is registered on the Peppol network with ID 0208:0536437813.
What is the enterprise number of MANAGEMENT CAROLINE VANDECASTEELE?
The enterprise number of MANAGEMENT CAROLINE VANDECASTEELE is BE0536437813.
When was MANAGEMENT CAROLINE VANDECASTEELE founded?
MANAGEMENT CAROLINE VANDECASTEELE was founded on 4 July 2013.